Has been essentially eradicated in a child making her just the second person ever said to be cured of h. I. V. Doctors at a mississippi hospital say they gave the girl an especially intensive threedrug regimen within three hours of birth before tests confirmed she was infeked and was not merely at high risk from her mother. The findings were announced in atlanta and is stirring much discussion about what it could mean for more than 300,000 babies born with h. I. V. Each year, mostly in africa. We talked to two experts now watching this closely. Dr. Anthony fauci of the National Institutes of health and Rowena Johnston Vice President and director of research at the American Foundation for aids research or a. M. F. A. R. Dr. Fauci, few babies are now born h. I. V. Infected in the United States because their mothers are usually already on apt eye retro viral medicine. But when it does happen whats the normal protocol . What usually happens . What happens is that if you get good prenatal c
In a child making her just the second person ever said to be cured of h. I. V. Doctors at a mississippi hospital say they gave the girl an especially intensive threedrug regimen within three hours of birth before tests confirmed she was infeked and was not merely at high risk from her mother. The findings were announced in atlanta and is stirring much discussion about what it could mean for more than 300,000 babies born with h. I. V. Each year, mostly in africa. We talked to two experts now watching this closely. Dr. Anthony fauci of the National Institutes of health and Rowena Johnston Vice President and director of research at the American Foundation for aids research or a. M. F. A. R. Dr. Fauci, few babies are now born h. I. V. Infected in the United States because their mothers are usually already on apt eye retro viral medicine. But when it does happen whats the normal protocol . What usually happens . What happens is that if you get good prenatal care, the mother if shes infected
amfAR, The Foundation for AIDS Research, has awarded Luis J. Montaner, D.V.M., D.Phil., in collaboration with Mohamed Abdel-Mohsen, Ph.D., a Target Grant for $397,663 over two years. Montaner, who leads The Wistar Institute's HIV Research Program, is studying the ability of a type of immune cell known as natural killer (NK) cells to kill HIV-infected cells.